These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28625271)

  • 1. [Advances in immunotherapeutic research of sepsis].
    Dong L; Lyu J; Ding L; Liu Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Feb; 29(2):184-187. PubMed ID: 28625271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.
    Patil NK; Bohannon JK; Sherwood ER
    Pharmacol Res; 2016 Sep; 111():688-702. PubMed ID: 27468649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the Study of Immunosuppressive Mechanisms in Sepsis.
    Fu X; Liu Z; Wang Y
    J Inflamm Res; 2023; 16():3967-3981. PubMed ID: 37706064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression.
    Shindo Y; Unsinger J; Burnham CA; Green JM; Hotchkiss RS
    Shock; 2015 Apr; 43(4):334-43. PubMed ID: 25565644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options.
    Liu D; Huang SY; Sun JH; Zhang HC; Cai QL; Gao C; Li L; Cao J; Xu F; Zhou Y; Guan CX; Jin SW; Deng J; Fang XM; Jiang JX; Zeng L
    Mil Med Res; 2022 Oct; 9(1):56. PubMed ID: 36209190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of Sepsis: Blind Alley or Call for Personalized Assessment?
    Prucha M; Zazula R; Russwurm S
    Arch Immunol Ther Exp (Warsz); 2017 Feb; 65(1):37-49. PubMed ID: 27554587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the understanding and treatment of sepsis-induced immunosuppression.
    Venet F; Monneret G
    Nat Rev Nephrol; 2018 Feb; 14(2):121-137. PubMed ID: 29225343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmed Cell Death-1/Programmed Death-ligand 1 Pathway: A New Target for Sepsis.
    Liu Q; Li CS
    Chin Med J (Engl); 2017 Apr; 130(8):986-992. PubMed ID: 28397730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alleviation of exhaustion-induced immunosuppression and sepsis by immune checkpoint blockers sequentially administered with antibiotics-analysis of a new mathematical model.
    Gillis A; Beil M; Halevi-Tobias K; van Heerden PV; Sviri S; Agur Z
    Intensive Care Med Exp; 2019 Jun; 7(1):32. PubMed ID: 31187301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of sepsis-induced immunosuppression and immunological modification therapies for sepsis.
    Ono S; Tsujimoto H; Hiraki S; Aosasa S
    Ann Gastroenterol Surg; 2018 Sep; 2(5):351-358. PubMed ID: 30238076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the pathophysiology and molecular basis of sepsis-associated organ dysfunction: Novel therapeutic implications and challenges.
    Hattori Y; Hattori K; Suzuki T; Matsuda N
    Pharmacol Ther; 2017 Sep; 177():56-66. PubMed ID: 28232275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis.
    Cao C; Yu M; Chai Y
    Cell Death Dis; 2019 Oct; 10(10):782. PubMed ID: 31611560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory role of the programmed cell death 1 signaling pathway in sepsis induced immunosuppression.
    Zhong S; Yin Y
    Front Immunol; 2023; 14():1183542. PubMed ID: 37292207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune dysregulation in sepsis: experiences, lessons and perspectives.
    Cao M; Wang G; Xie J
    Cell Death Discov; 2023 Dec; 9(1):465. PubMed ID: 38114466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy in sepsis - brake or accelerate?
    Steinhagen F; Schmidt SV; Schewe JC; Peukert K; Klinman DM; Bode C
    Pharmacol Ther; 2020 Apr; 208():107476. PubMed ID: 31931100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune disorders in sepsis and their treatment as a significant problem of modern intensive care.
    Łysenko L; Leśnik P; Nelke K; Gerber H
    Postepy Hig Med Dosw (Online); 2017 Aug; 71(1):703-712. PubMed ID: 28894043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balance between Hyperinflammation and Immunosuppression in Sepsis.
    Yadav H; Cartin-Ceba R
    Semin Respir Crit Care Med; 2016 Feb; 37(1):42-50. PubMed ID: 26820273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Immune Cell Checkpoints during Sepsis.
    Patil NK; Guo Y; Luan L; Sherwood ER
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29135922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in understanding sepsis.
    Shimaoka M; Park EJ
    Eur J Anaesthesiol Suppl; 2008; 42():146-53. PubMed ID: 18289433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-7 and Its Beneficial Role in Sepsis-Induced T Lymphocyte Dysfunction.
    de Roquetaillade C; Monneret G; Gossez M; Venet F
    Crit Rev Immunol; 2018; 38(6):433-451. PubMed ID: 31002599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.